Clinical Trial: Vitamin D3 and Monocyte Responses in Pregnant Women With Pulmonary Tuberculosis

U.S., Oct. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07907094) titled 'Vitamin D3 and Monocyte Responses in Pregnant Women With Pulmonary Tuberculosis' on Oct. 25.

Brief Summary: This randomized controlled trial evaluated the effects of adjunctive vitamin D3 supplementation on circulating monocyte subsets and the expression of vitamin D receptor (VDR) and interleukin-6 (IL-6) in pregnant women with pulmonary tuberculosis.

A total of 32 pregnant women with pulmonary tuberculosis were allocated to receive either standard first-line anti-tuberculosis treatment alone or standard treatment plus oral vitamin D3 supplementation at a dose of 50,000 IU once weekly for eight weeks.

Serum 25-hydroxyvitamin D [2...